The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength
- PMID: 31207357
- PMCID: PMC6708759
- DOI: 10.1016/j.bone.2019.06.010
The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength
Abstract
The genetic components of microbial species that inhabit the body are known collectively as the microbiome. Modifications to the microbiome have been implicated in disease processes throughout the body and have recently been shown to influence bone. Prior work has associated changes in the microbial taxonomy (phyla, class, species, etc.) in the gut with bone phenotypes but has provided limited information regarding mechanisms. With the goal of achieving a more mechanistic understanding of the effects of the microbiome on bone, we perform a metagenomic analysis of the gut microbiome that provides information on the functional capacity of the microbes (all microbial genes present) rather than only characterizing the microbial taxa. Male C57Bl/6 mice were subjected to disruption of the gut microbiota (ΔMicrobiome) using oral antibiotics (from 4 to 16 weeks of age) or remained untreated (n = 6-7/group). Disruption of the gut microbiome in this manner has been shown to lead to reductions in tissue mechanical properties and whole bone strength in adulthood with only minor changes in bone geometry and density. ΔMicrobiome led to modifications in the abundance of microbial genes responsible for the synthesis of the bacterial cell wall and capsule; bacterially synthesized carbohydrates; and bacterially synthesized vitamins (B and K) (p < 0.01). Follow up analysis focused on vitamin K, a factor that has previously been associated with bone health. The vitamin K content of the cecum, liver and kidneys was primarily microbe-derived forms of vitamin K (menaquinones) and was decreased by 32-66% in ∆Microbiome mice compared to untreated animals (p < 0.01). Bone mineral crystallinity determined using Raman spectroscopy was decreased in ∆Microbiome mice (p = 0.01). This study illustrates the use of metagenomic analysis to link the microbiome to bone phenotypes and provides preliminary findings implicating microbially synthesized vitamin-K as a regulator of bone matrix quality.
Keywords: Biomechanics; Bone matrix; Microbiome; Osteoimmunology; Osteoporosis; Raman spectroscopy.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosures
All authors state that they have no conflicts of interest.
Figures
Similar articles
-
The Gut Microbiome and Bone Strength.Curr Osteoporos Rep. 2020 Dec;18(6):677-683. doi: 10.1007/s11914-020-00627-x. Epub 2020 Oct 8. Curr Osteoporos Rep. 2020. PMID: 33030683 Free PMC article. Review.
-
Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material Properties.J Bone Miner Res. 2017 Jun;32(6):1343-1353. doi: 10.1002/jbmr.3114. Epub 2017 Mar 27. J Bone Miner Res. 2017. PMID: 28244143 Free PMC article.
-
Components of the Gut Microbiome That Influence Bone Tissue-Level Strength.J Bone Miner Res. 2021 Sep;36(9):1823-1834. doi: 10.1002/jbmr.4341. Epub 2021 Jun 4. J Bone Miner Res. 2021. PMID: 33999456 Free PMC article.
-
Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.PLoS One. 2020 Jan 24;15(1):e0227886. doi: 10.1371/journal.pone.0227886. eCollection 2020. PLoS One. 2020. PMID: 31978162 Free PMC article.
-
Bone Mechanical Function and the Gut Microbiota.Adv Exp Med Biol. 2017;1033:249-270. doi: 10.1007/978-3-319-66653-2_12. Adv Exp Med Biol. 2017. PMID: 29101659 Review.
Cited by
-
Inflammation and gut dysbiosis as drivers of CKD-MBD.Nat Rev Nephrol. 2023 Oct;19(10):646-657. doi: 10.1038/s41581-023-00736-7. Epub 2023 Jul 24. Nat Rev Nephrol. 2023. PMID: 37488276 Review.
-
Racial and Ethnic Differences in Studies of the Gut Microbiome and Osteoporosis.Curr Osteoporos Rep. 2023 Oct;21(5):578-591. doi: 10.1007/s11914-023-00813-7. Epub 2023 Aug 19. Curr Osteoporos Rep. 2023. PMID: 37597104 Review.
-
The Gut Microbiome and Bone Strength.Curr Osteoporos Rep. 2020 Dec;18(6):677-683. doi: 10.1007/s11914-020-00627-x. Epub 2020 Oct 8. Curr Osteoporos Rep. 2020. PMID: 33030683 Free PMC article. Review.
-
Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.Front Endocrinol (Lausanne). 2023 Dec 4;14:1278505. doi: 10.3389/fendo.2023.1278505. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38116314 Free PMC article.
-
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?Toxins (Basel). 2020 May 27;12(6):351. doi: 10.3390/toxins12060351. Toxins (Basel). 2020. PMID: 32471179 Free PMC article.
References
-
- Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, Sogin ML, The Microbiome and Human Biology, Annu Rev Genomics Hum Genet (2017). - PubMed
-
- Schwarzer M, Makki K, Storelli G, Machuca-Gayet I, Srutkova D, Hermanova P, Martino ME, Balmand S, Hudcovic T, Heddi A, Rieusset J, Kozakova H, Vidal H, Leulier F, Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition, Science 351(6275) (2016) 854–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources